Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionExodusPoint Capital Management, LP
Latest Disclosed Ownership47,750 shares
Latest Disclosed Value $ 2,691,190
ExodusPoint Capital Management, LP ownership in HAE / Haemonetics Corporation

On May 14, 2026 - ExodusPoint Capital Management, LP filed a 13F-HR form disclosing ownership of 47,750 shares of Haemonetics Corporation (US:HAE) valued at $2,691,190 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of Haemonetics Corporation. The current value of the position is $3,403,620 USD.

ExodusPoint Capital Management, LP has a history of taking positions in derivatives of the underlying security (HAE) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

HAE / Haemonetics Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 47,750 47,750 2,691 0.0217
2026-02-17 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 0 -311,851 -100.00 0 -100.00
2025-11-14 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 311,851 185,336 146.49 15,200 168,777.78 0.1553
2025-08-13 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 126,515 62,174 96.63 9 125.00 0.0828
2025-05-14 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 64,341 49,898 345.48 4 300.00 0.0404
2025-02-12 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 14,443 -66,500 -82.16 1 -83.33 0.0077
2024-11-12 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 80,943 51,667 176.48 7 200.00 0.0396
2024-08-13 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 29,276 29,276 2 0.0165
2023-11-09 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 0 -10,423 -100.00 0 0.0000
2023-08-11 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 10,423 -39,809 -79.25 1 -100.00 0.0072
2023-05-11 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 50,232 12,332 32.54 4 100.00 0.0344
2023-02-13 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 37,900 37,900 3 0.0433
2022-05-12 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 0 -5,726 -100.00 0 -100.00
2022-02-11 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 5,726 5,726 304 0.0031
2021-08-16 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 0 -6,015 -100.00 0 -100.00
2021-05-17 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 6,015 -32,473 -84.37 668 -85.38 0.0097
2021-02-16 2020-12-31 13F HAEMONETICS COM 405024100 38,488 -14,171 -26.91 4,570 -0.52 0.0445
2020-11-16 2020-09-30 13F HAEMONETICS COM 405024100 52,659 14,258 37.13 4,594 33.59 0.0915
2020-08-14 2020-06-30 13F HAEMONETICS COM 405024100 38,401 38,401 3,439 0.0893
2020-05-15 2020-03-31 13F HAEMONETICS COM 405024100 0 -33,437 -100.00 0 -100.00
2020-02-14 2019-12-31 13F HAEMONETICS COM 405024100 33,437 33,437 3,842 0.0721
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-02-16 2020-12-31 13F HAEMONETICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F HAEMONETICS COM Call 20,000 1,745 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.